Vietnam Pharmaceuticals Q3-2012

Only available on StudyMode
  • Download(s) : 85
  • Published : March 18, 2013
Open Document
Text Preview
Vietnam Pharmaceuticals & Healthcare Report Q3 2012 New Market Research Report Posted on Thursday, September 20, 2012 http://www.sbwire.com/press-releases/vietnam-pharmaceuticals-healthcare-report-q3-2012-new-market-research-report163635.htm Recently published research from Business Monitor International, "Vietnam Pharmaceuticals & Healthcare Report Q3 2012", is now available at Fast Market Research Boston, MA -- (SBWIRE) -- 09/20/2012 -- BMI View: Vietnam continues to be viewed as a promising, but risky, commercial proposition. We envisage continued involvement of multinational companies in both its pharmaceutical and healthcare markets, although the country's longer term potential will continue to be clouded by the lacking intellectual property (IP) climate and the prevalence of corruption, among other issues. Headline Expenditure Projections - Pharmaceuticals: VND39,003bn (US$1.89bn) in 2011 to VND45,284bn (US$2.15bn) in 2012; +16.1% in local currency terms and +14.0% in US dollar terms. Forecast unchanged from Q312. - Healthcare: VND157, 234bn (US$7.61bn) in 2011 to VND180,892bn (US$8.60bn) in 2012; +15.0% in local currency terms and +13.0% in US dollar terms. Forecast broadly unchanged from Q312, despite lowering of historical data. - Medical devices: VND15,137bn (US$733mn) in 2011 to VND17,026bn (US$809mn) in 2012; +12.5% in local currency terms and +10.4% in US dollar terms. Forecast slightly lower from Q312, party on account of changed historical data. View Full Report Details and Table of Contents Risk/Reward Rating: In the current quarter's regional Risk/Reward Rating (RRR), Vietnam scores 40.9, which is lower in relation to Q212, but still ranks the country 14th out of the 18 key markets surveyed in Asia Pacific. Globally, Vietnam is 72nd out of 95 countries assessed. Its longer-term attractiveness is clouded by low per capita spending and also by the risky operating environment, complete with widespread prevalence of counterfeit drugs, despite the...
tracking img